TNF and rheumatoid arthritis: In the study by Durez et al. [92], the authors compared the short-term clinical and biological effects of intravenous pulse methylprednisolone (MP) and the tumor necrosis factor (TNF) antagonist infliximab (IFX) in patients with severe RA treated with methotrexate (MTX).